Panic attacks and agoraphobia: Low dose clomipramine treatment

dc.creatorGloger, Sergio
dc.creatorGrunhaus, Leon
dc.creatorGladic, Danica
dc.creatorO’Ryan, Francisco
dc.creatorCohen, Leon
dc.creatorCodner, Sabina
dc.date.accessioned2019-01-29T12:39:52Z
dc.date.available2019-01-29T12:39:52Z
dc.date.created2019-01-29T12:39:52Z
dc.date.issued1989
dc.identifierJournal of Clinical Psychopharmacology, Volumen 9, Issue 1, 1989, Pages 28-32
dc.identifier1533712X
dc.identifier02710749
dc.identifierhttps://repositorio.uchile.cl/handle/2250/159663
dc.description.abstractSeventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8-week open trial. Panic attacks ceased completely in 13 patients and markedly decreased in the other four without additional therapeutic measures. Avoidance behavior disappeared in five of the seven agoraphobic patients. Overall mean dosage was 45 mg/day, with eight patients receiving clomipramine 25 mg or less. Higher doses were needed when agoraphobia was present. These results are discussed in conjunction with previous findings and lend support to serotonergic involvement in panic anxiety. Further double-blind studies are needed to confirm these results.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Clinical Psychopharmacology
dc.subjectPsychiatry and Mental Health
dc.subjectPharmacology (medical)
dc.titlePanic attacks and agoraphobia: Low dose clomipramine treatment
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución